{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:50:18Z","timestamp":1770817818178,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,11]]},"DOI":"10.7759\/cureus.103409","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:42:09Z","timestamp":1770810129000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Histiocytic Sarcoma in Childhood"],"prefix":"10.7759","author":[{"given":"Haroula","family":"Tsipou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Avgerinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Glentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Stefanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Kattamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi E","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013, 53:1-8. 10.3960\/jslrt.53.1","journal-title":"J Clin Exp Hematop"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0349-RS","article-title":"Histiocytic sarcoma","volume":"144","author":"Hung YP","year":"2020","unstructured":"Hung YP, Qian X. Histiocytic sarcoma. Arch Pathol Lab Med. 2020, 144:650-4. 10.5858\/arpa.2018-0349-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1492128","article-title":"Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma","volume":"60","author":"Kommalapati A","year":"2019","unstructured":"Kommalapati A, Tella SH, Go RS, Goyal G. Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019, 60:553-5. 10.1080\/10428194.2018.1492128","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178554","article-title":"Histiocytic sarcoma: a review and update","volume":"26","author":"Shinohara Y","year":"2025","unstructured":"Shinohara Y, Nakayama S, Aoki M, Nishio J. Histiocytic sarcoma: a review and update. Int J Mol Sci. 2025, 26:8554. 10.3390\/ijms26178554","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.36401\/JIPO-23-11","article-title":"Histiocytic sarcoma treated with pembrolizumab: a case report and literature review","volume":"6","author":"Huff D","year":"2023","unstructured":"Huff D, Fortin Ensign S, Ryan MS, Palmer J, Munoz J. Histiocytic sarcoma treated with pembrolizumab: a case report and literature review. J Immunother Precis Oncol. 2023, 6:198-202. 10.36401\/JIPO-23-11","journal-title":"J Immunother Precis Oncol"},{"key":"ref7","unstructured":"LCH-IV, International collaborative treatment protocol for children and adolescents with Langerhans cell histiocytosis. (2025). Accessed. 2025: https:\/\/clinicaltrials.gov\/study\/NCT02205762."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5045\/br.2016.51.4.220","article-title":"Salvage treatment of relapsed\/refractory LCH","volume":"51","author":"Seo JJ","year":"2016","unstructured":"Seo JJ. Salvage treatment of relapsed\/refractory LCH. Blood Res. 2016, 51:220-2. 10.5045\/br.2016.51.4.220","journal-title":"Blood Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati A","year":"2018","unstructured":"Kommalapati A, Tella SH, Durkin M, Go RS, Goyal G. Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018, 131:265-8. 10.1182\/blood-2017-10-812495","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2020.170","article-title":"Pediatric multifocal histiocytic sarcoma- a fatal diagnosis not to miss!","volume":"10","author":"Shangpliang D","year":"2020","unstructured":"Shangpliang D, Baishya P, Raphael V, Dey B, Jagtap VK. Pediatric multifocal histiocytic sarcoma- a fatal diagnosis not to miss!. Autops Case Rep. 2020, 10:e2020170. 10.4322\/acr.2020.170","journal-title":"Autops Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28074","article-title":"Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients","volume":"67","author":"Bleeke M","year":"2020","unstructured":"Bleeke M, Johann P, Gr\u00f6bner S, et al.. Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients. Pediatr Blood Cancer. 2020, 67:e28074. 10.1002\/pbc.28074","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03695-8","article-title":"Histiocytic sarcoma following CAR T-cell therapy: a case report","volume":"119","author":"An K","year":"2024","unstructured":"An K, He Y, Tang Y, Gu X, Qian J, Li B. Histiocytic sarcoma following CAR T-cell therapy: a case report. Int J Hematol. 2024, 119:338-41. 10.1007\/s12185-023-03695-8","journal-title":"Int J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile JF","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, et al.. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016, 127:2672-81. 10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"key":"ref14","article-title":"Histiocytic sarcoma","volume":"22","author":"Tocut M","year":"2020","unstructured":"Tocut M, Vaknine H, Potachenko P, Elias S, Zandman-Goddard G. Histiocytic sarcoma. Isr Med Assoc J. 2020, 22:645-7.","journal-title":"Isr Med Assoc J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127599","article-title":"Case report: targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis","volume":"14","author":"Zhao Y","year":"2023","unstructured":"Zhao Y, Deng Y, Jiang Y, et al.. Case report: targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis. Front Immunol. 2023, 14:1127599. 10.3389\/fimmu.2023.1127599","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2023.12.009","article-title":"Histiocytic sarcoma mimicking localized tenosynovial giant cell tumor in the pediatric foot: a rare case report with MRI findings","volume":"19","author":"Khil EK","year":"2024","unstructured":"Khil EK, Cha JG, Yoon YS, Kim HK. Histiocytic sarcoma mimicking localized tenosynovial giant cell tumor in the pediatric foot: a rare case report with MRI findings. Radiol Case Rep. 2024, 19:1149-53. 10.1016\/j.radcr.2023.12.009","journal-title":"Radiol Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27054","article-title":"Histiocytic sarcoma in a child-successful management and long-term survival with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"65","author":"Sandler G","year":"2018","unstructured":"Sandler G, Franklin A, Hayes-Jordan A. Histiocytic sarcoma in a child-successful management and long-term survival with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Pediatr Blood Cancer. 2018, 65:e27054. 10.1002\/pbc.27054","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-022-00562-x","article-title":"A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab","volume":"11","author":"Furui Y","year":"2022","unstructured":"Furui Y, Kurata T, Komori K, et al.. A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab. Int Cancer Conf J. 2022, 11:280-5. 10.1007\/s13691-022-00562-x","journal-title":"Int Cancer Conf J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.179150","article-title":"Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma","volume":"103","author":"Voruz S","year":"2018","unstructured":"Voruz S, Cairoli A, Naveiras O, et al.. Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma. Haematologica. 2018, 103:e39-41. 10.3324\/haematol.2017.179150","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam V","year":"2019","unstructured":"Shanmugam V, Griffin GK, Jacobsen ED, Fletcher CD, Sholl LM, Hornick JL. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019, 32:830-43. 10.1038\/s41379-018-0200-x","journal-title":"Mod Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-017-2176-1","article-title":"Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases","volume":"471","author":"Facchetti F","year":"2017","unstructured":"Facchetti F, Pileri SA, Lorenzi L, et al.. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch. 2017, 471:467-89. 10.1007\/s00428-017-2176-1","journal-title":"Virchows Arch"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464229-successful-treatment-of-histiocytic-sarcoma-in-childhood","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:42:11Z","timestamp":1770810131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464229-successful-treatment-of-histiocytic-sarcoma-in-childhood"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.103409","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}